Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

2.

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide.

Koekkoek JA, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Reijneveld JC, Taphoorn MJ.

J Neurooncol. 2016 Jan;126(2):347-54. doi: 10.1007/s11060-015-1975-y.

3.

Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information.

Mörén L, Bergenheim AT, Ghasimi S, Brännström T, Johansson M, Antti H.

Metabolites. 2015 Sep 15;5(3):502-20. doi: 10.3390/metabo5030502.

4.

Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.

Sarmiento JM, Venteicher AS, Patil CG.

Cochrane Database Syst Rev. 2015 Jun 29;(6):CD009229. doi: 10.1002/14651858.CD009229.pub2. Review.

5.

Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.

Kim MM, Lawrence TS, Cao Y.

Semin Radiat Oncol. 2015 Jul;25(3):172-80. doi: 10.1016/j.semradonc.2015.02.003. Review.

6.

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.

Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD.

Acta Neuropathol. 2015 Apr;129(4):585-96. doi: 10.1007/s00401-015-1398-z.

7.

Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.

Gozé C, Blonski M, Le Maistre G, Bauchet L, Dezamis E, Page P, Varlet P, Capelle L, Devaux B, Taillandier L, Duffau H, Pallud J.

Neuro Oncol. 2014 Aug;16(8):1100-9. doi: 10.1093/neuonc/nou085.

8.
9.

Supratentorial gliomas in eloquent areas: which parameters can predict functional outcome and extent of resection?

Spena G, D'Agata F, Panciani PP, Buglione di Monale M, Fontanella MM.

PLoS One. 2013 Dec 5;8(12):e80916. doi: 10.1371/journal.pone.0080916.

10.

Resection probability maps for quality assessment of glioma surgery without brain location bias.

De Witt Hamer PC, Hendriks EJ, Mandonnet E, Barkhof F, Zwinderman AH, Duffau H.

PLoS One. 2013 Sep 6;8(9):e73353. doi: 10.1371/journal.pone.0073353.

11.

Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.

Chaichana KL, Pendleton C, Chambless L, Camara-Quintana J, Nathan JK, Hassam-Malani L, Li G, Harsh GR 4th, Thompson RC, Lim M, Quinones-Hinojosa A.

J Clin Neurosci. 2013 Oct;20(10):1422-6. doi: 10.1016/j.jocn.2013.02.007.

12.

Current treatment of low grade gliomas.

van den Bent MJ, Snijders TJ, Bromberg JE.

Memo. 2012 Sep;5(3):223-227.

13.

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas.

Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D.

Neuro Oncol. 2013 Jun;15(6):682-90. doi: 10.1093/neuonc/not006.

14.

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.

Reardon DA, Desjardins A, Vredenburgh JJ, Herndon JE 2nd, Coan A, Gururangan S, Peters KB, McLendon R, Sathornsumetee S, Rich JN, Lipp ES, Janney D, Friedman HS.

Cancer. 2012 Oct 1;118(19):4759-67. doi: 10.1002/cncr.26541.

15.

Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery.

Castellano A, Bello L, Michelozzi C, Gallucci M, Fava E, Iadanza A, Riva M, Casaceli G, Falini A.

Neuro Oncol. 2012 Feb;14(2):192-202. doi: 10.1093/neuonc/nor188.

16.

Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement.

Belhawi SM, Hoefnagels FW, Baaijen JC, Aliaga ES, Reijneveld JC, Heimans JJ, Barkhof F, Vandertop WP, Hamer PC.

Eur Radiol. 2011 Jul;21(7):1526-34. doi: 10.1007/s00330-011-2081-y.

17.

Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM.

J Clin Oncol. 2010 Aug 20;28(24):3838-43. doi: 10.1200/JCO.2010.30.0582.

18.

Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article.

Chang EF, Clark A, Smith JS, Polley MY, Chang SM, Barbaro NM, Parsa AT, McDermott MW, Berger MS.

J Neurosurg. 2011 Mar;114(3):566-73. doi: 10.3171/2010.6.JNS091246.

19.

Management of low-grade glioma.

Pouratian N, Schiff D.

Curr Neurol Neurosci Rep. 2010 May;10(3):224-31. doi: 10.1007/s11910-010-0105-7. Review.

Supplemental Content

Support Center